{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:25:19Z","timestamp":1782901519011,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"am","delay-in-days":308,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43AI172654"],"award-info":[{"award-number":["R43AI172654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jconrel.2025.113662","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:25:42Z","timestamp":1743254742000},"page":"113662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection"],"prefix":"10.1016","volume":"382","author":[{"given":"Keiichiro","family":"Kushiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Hammers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley B.","family":"Flowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysha","family":"Panjwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"McSweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Moench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","article-title":"Unintended pregnancy: worldwide levels, trends, and outcomes","volume":"41","author":"Singh","year":"2010","journal-title":"Stud. Fam. Plan."},{"issue":"9","key":"10.1016\/j.jconrel.2025.113662_bb0010","doi-asserted-by":"crossref","first-page":"e1152","DOI":"10.1016\/S2214-109X(20)30315-6","article-title":"Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990-2019","volume":"8","author":"Bearak","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jconrel.2025.113662_bb0015","series-title":"Sexually Transmitted Diseases Treatment Guidelines","volume":"vol. 59(No. RR-12)","year":"2010"},{"key":"10.1016\/j.jconrel.2025.113662_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106760","article-title":"An update on antiviral antibody-based biopharmaceuticals","volume":"86","author":"Ahangarzadeh","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.113662_bb0025","series-title":"Fundamental Immunology","first-page":"421","article-title":"Antigen-antibody interactions and monoclonal antibodies","author":"Berzofsky","year":"1993"},{"key":"10.1016\/j.jconrel.2025.113662_bb0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.actbio.2016.07.019","article-title":"Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus","volume":"43","author":"Henry","year":"2016","journal-title":"Acta Biomater."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/mi.2011.41","article-title":"Secretory IgA\u2019s complex roles in immunity and mucosal homeostasis in the gut","volume":"4","author":"Mantis","year":"2011","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0040","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01709-2016","article-title":"Influenza-binding antibodies immobilise influenza viruses in fresh human airway mucus","volume":"49","author":"Wang","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113662_bb0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/mi.2013.120","article-title":"IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0050","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.1038\/s41598-018-28242-y","article-title":"Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro","volume":"8","author":"Devito","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113662_bb0055","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1097\/QAD.0000000000001521","article-title":"Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV","volume":"31","author":"Anderson","year":"2017","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.jconrel.2025.113662_bb0060","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41385-018-0054-z","article-title":"Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition","volume":"11","author":"Schroeder","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113662_bb0065","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.1600374","article-title":"Phase-variable Heptose I glycan extensions modulate efficacy of 2C7 vaccine antibody directed against Neisseria gonorrhoeae Lipooligosaccharide","volume":"196","author":"Chakraborti","year":"2016","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.jconrel.2025.113662_bb0070","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220110","article-title":"Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity","volume":"219","author":"Backes","year":"2022","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113662_bb0075","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/169.3.647","article-title":"Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections","volume":"169","author":"Whaley","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0897.1985.tb00333.x","article-title":"Induction of the shaking phenomenon by IgA class antispermatozoal antibodies from serum","volume":"9","author":"Clarke","year":"1985","journal-title":"Am. J. Reprod. Immunol. Microbiol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113662_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0015-0282(16)41726-7","article-title":"The sperm-cervical mucus contact test: a preliminary report","volume":"27","author":"Kremer","year":"1976","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1095\/biolreprod56.1.153","article-title":"Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits","volume":"56","author":"Castle","year":"1997","journal-title":"Biol. Reprod."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0095","doi-asserted-by":"crossref","first-page":"716.e1","DOI":"10.1016\/j.ajog.2023.02.024","article-title":"ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study","volume":"228","author":"Thurman","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"48","key":"10.1016\/j.jconrel.2025.113662_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107832118","article-title":"Hexavalent sperm-binding IgG antibody released from vaginal film for development of potent on-demand nonhormonal female contraception","volume":"118","author":"Shrestha","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.113662_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103478","article-title":"Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women","volume":"69","author":"Baldeon-Vaca","year":"2021","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s44222-023-00040-w","article-title":"Delivery technologies for women\u2019s health applications","volume":"1","author":"Swingle","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0378(98)00041-2","article-title":"Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina","volume":"40","author":"Zeitlin","year":"1998","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113662_bb0120","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0010-7824(97)00154-6","article-title":"Tests of vaginal microbicides in the mouse genital herpes model","volume":"56","author":"Zeitlin","year":"1997","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nbt0496-468","article-title":"Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes","volume":"14","author":"Sherwood","year":"1996","journal-title":"Nat. Biotechnol."},{"issue":"13","key":"10.1016\/j.jconrel.2025.113662_bb0130","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/4344","article-title":"A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes","volume":"16","author":"Zeitlin","year":"1998","journal-title":"Nat. Biotechnol."},{"issue":"606","key":"10.1016\/j.jconrel.2025.113662_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5219","article-title":"Engineering sperm-binding IgG antibodies for the development of an effective nonhormonal female contraception","volume":"13","author":"Shrestha","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/biolre\/ioaa221","article-title":"Surrogate post-coital testing for contraceptive efficacy against human sperm activity in the ovine vaginal modeldagger","volume":"104","author":"Zhu","year":"2021","journal-title":"Biol. Reprod."},{"issue":"11","key":"10.1016\/j.jconrel.2025.113662_bb0145","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1128\/JCM.36.11.3198-3204.1998","article-title":"Characterization of a type-common human recombinant monoclonal antibody to herpes simplex virus with high therapeutic potential","volume":"36","author":"De Logu","year":"1998","journal-title":"J. Clin. Microbiol."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/aid.2016.0040","article-title":"Comparison of Dapivirine vaginal gel and film formulation pharmacokinetics and pharmacodynamics (FAME 02B)","volume":"33","author":"Robinson","year":"2017","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003495","article-title":"Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): a phase I randomized trial","volume":"18","author":"Politch","year":"2021","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0165","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/pharmaceutics6040616","article-title":"Evaluation of rapidly disintegrating vaginal tablets of Tenofovir, Emtricitabine and their combination for HIV-1 prevention","volume":"6","author":"Clark","year":"2014","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jconrel.2025.113662_bb0170","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.xphs.2018.06.002","article-title":"Development of a vaginal fast-dissolving insert combining Griffithsin and carrageenan for potential use against sexually transmitted infections","volume":"107","author":"Lal","year":"2018","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113662_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080374","article-title":"Topical inserts: a versatile delivery form for HIV prevention","volume":"11","author":"Peet","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1073\/pnas.91.1.355","article-title":"Recombinant human fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro","volume":"91","author":"Burioni","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113662_bb0185","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/infdis\/jiz412","article-title":"Personal and clinical vaginal lubricants: impact on local vaginal microenvironment and implications for epithelial cell host response and barrier function","volume":"220","author":"Wilkinson","year":"2019","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113662_bb0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.5713\/ab.21.0072","article-title":"Semen evaluation: methodological advancements in sperm quality-specific fertility assessment - a review","volume":"34","author":"Tanga","year":"2021","journal-title":"Anim. Biosci."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0195","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"Moss","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113662_bb0200","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/AAC.00547-13","article-title":"Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model","volume":"57","author":"Moss","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2025.113662_bb0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2014.12.005","article-title":"Preclinical assessments of vaginal microbicide candidate safety and efficacy","volume":"92","author":"Fernandez-Romero","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2025.113662_bb0210","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1128\/AAC.04954-14","article-title":"The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides","volume":"59","author":"Holt","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0010-7824(96)00081-9","article-title":"Lea\u2019s shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide","volume":"53","author":"Mauck","year":"1996","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00068-2","article-title":"A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho all-flex diaphragm. The FemCap Investigators\u2019 Group","volume":"60","author":"Mauck","year":"1999","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/AOG.0b013e3181fc3b1a","article-title":"Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial","volume":"116","author":"Burke","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/AOG.0000000000000721","article-title":"Contraceptive efficacy, safety, fit, and acceptability of a single-size diaphragm developed with end-user input","volume":"125","author":"Schwartz","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.jconrel.2025.113662_bb0235","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.AOG.0000278078.45640.13","article-title":"Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial","volume":"110","author":"Barnhart","year":"2007","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2025.113662_bb0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.AOG.0000483485.43767.2e","article-title":"Efficacy, safety, and acceptability of Acidform (Amphora) and Nonoxynol-9 contraceptive vaginal gels [16N]","volume":"127","author":"Barnhart","year":"2016","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113662_bb0245","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/OLQ.0b013e31819496e4","article-title":"High resolution imaging of epithelial injury in the sheep cervicovaginal tract: a promising model for testing safety of candidate microbicides","volume":"36","author":"Vincent","year":"2009","journal-title":"Sex. Transm. Dis."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0250","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.1965423","article-title":"Passive immunization of the human vagina","volume":"18","author":"Anderson","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0255","first-page":"262","article-title":"US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives","volume":"4","author":"Wang","year":"2021","journal-title":"Antib. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2025.113662_bb0260","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.xphs.2021.11.008","article-title":"Ongoing challenges to develop high concentration monoclonal antibody-based formulations for subcutaneous administration: quo Vadis?","volume":"111","author":"Jiskoot","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0265","article-title":"Current advancements in addressing key challenges of therapeutic antibody design, manufacture, and formulation","volume":"8","author":"Sifniotis","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jconrel.2025.113662_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124423","article-title":"Development of monoclonal antibodies in tablet form: a new approach for local delivery","volume":"661","author":"Auffray","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.113662_bb0275","article-title":"Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men","volume":"4","author":"Wilkinson","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2025.113662_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ph15080975","article-title":"Intestinal absorption study: challenges and absorption enhancement strategies in improving oral drug delivery","volume":"15","author":"Azman","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12 Suppl 2","key":"10.1016\/j.jconrel.2025.113662_bb0285","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/infdis\/jiaa762","article-title":"Protection and risk: male and female genital microbiota and sexually transmitted infections","volume":"223","author":"Tuddenham","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0290","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MAJ.0b013e31823ea228","article-title":"The microbiota of the vagina and its influence on women\u2019s health and disease","volume":"343","author":"Martin","year":"2012","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2016.12.013","article-title":"Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV Acquisition in Young South African Women","volume":"46","author":"Gosmann","year":"2017","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113662_bb0300","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.jconrel.2025.113662_bb0305","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1172\/JCI57172","article-title":"Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective","volume":"121","author":"Brotman","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.jconrel.2025.113662_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01084-15","article-title":"Enhanced trapping of HIV-1 by human Cervicovaginal mucus is associated with Lactobacillus crispatus-dominant microbiota","volume":"6","author":"Nunn","year":"2015","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.jconrel.2025.113662_bb0315","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/infdis\/jiy230","article-title":"ZMapp reinforces the airway mucosal barrier against Ebola virus","volume":"218","author":"Yang","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2025.113662_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5534\/wjmh.210022","article-title":"Standardized laboratory procedures, quality control and quality assurance are key requirements for accurate semen analysis in the evaluation of infertile male","volume":"40","author":"Agarwal","year":"2022","journal-title":"World J. Mens Health"},{"issue":"2","key":"10.1016\/j.jconrel.2025.113662_bb0325","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.contraception.2008.04.002","article-title":"Baseline colposcopic findings in women entering studies on female vaginal products","volume":"78","author":"O\u2019Neill","year":"2008","journal-title":"Contraception"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:03:07Z","timestamp":1777870987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":65,"alternative-id":["S0168365925002822"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113662","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113662"}}